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TGF- Released by Apoptotic T Cells
Contributes to an Immunosuppressive Milieu
(Griffith et al., 1996), suggesting a possible soluble inhib-
itory molecule(s) in this tolerance induction.
Mutation of individual genes in mice represents a valu-
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Oral Infection and Immunity Branch able tool to study the function of the targeted genes.
That similar phenotypes often manifest among mice de-National Institute of Dental and Craniofacial Research
National Institutes of Health ficient in quite different genes has been perplexing. In
this regard, deletion of the genes for Fas death receptorsBethesda, Maryland 20892
or Fas ligand (FasL) (Nagata, 1997) results in dysregula-
tion of T cell apoptosis, prolonged life span of potential
autoreactive T cells, inflammation, autoimmune-likeSummary
syndrome, and finally an early demise. Furthermore, mu-
tation of IL-2 (Sadlack et al., 1993) also causes uncon-T cell apoptosis is critical to development and homeo-
stasis of the immune system. The most salient feature trolled T cell proliferation (Sadlack et al., 1995), since
IL-2-mediated signals are prerequisites for efficient apo-of apoptosis is the lack of an attendant inflammatory
response or tissue damage. Here, we present evidence ptosis of activated effector T cells (Lenardo et al., 1999;
Lenardo, 1991; Van Parijs et al., 1999). Both IL-2 and Tthat apoptotic T cells release TGF-, thereby contrib-
uting to an immunosuppressive milieu. Apoptotic T cell receptor (TCR) (Mombaerts et al., 1993) null mice
develop similar inflammatory diseases, including inflam-cells released not only latent but also bio-active TGF-.
Nonetheless, TGF- transcription was not upregu- matory bowel disease (IBD) and untimely death. How-
ever, the inflammatory response of these mutated micelated, suggesting release of existing rather than syn-
thesis of new TGF-. Localized within the intracellular may not be solely due to the prolonged life span of
autoreactive T cells, since deletion of the IL-10 genemembrane-bound compartment, which includes mito-
chondria, TGF-was redistributed into the cytosol fol- (Kuhn et al., 1993) resulted in a similar phenotype with
IBD, without a decrease in T cell apoptosis. Even morelowing loss of mitochondrial membrane potential.
TGF- secreted from apoptotic T cells inhibited proin- paradoxically, mutation of the TGF-1 gene, which actu-
ally enhances T cell apoptosis (W. C. et al.,unpublishedflammatory cytokine production by activated macro-
phages to foster immune suppression. These findings data), drives massive and lethal inflammation (Kulkarni
et al., 1993; Shull et al., 1992). Thus, despite deletion ofbroaden the potential mechanisms whereby induction
of immune tolerance or deficiency occurs through T distinct immunoregulatory genes, there must be some
shared mechanisms involved in the pathogenesiscell deletion.
among these mice.
The most salient feature of apoptosis is the lack ofIntroduction
an attendant inflammatory response or tissue damage.
This was originally thought to be a passive process andT cell apoptosis is critical to the development and ho-
meostasis of the immune system (Lenardo et al., 1999). attributed to the rapid phagocytosis of apoptotic cells
before lysis, thereby preventing the release of inflamma-Although deletion of antigen-specific T cells has been
considered as one of the most important mechanisms in tory or damaging factors. Recent evidence however has
indicated that apoptotic cells may be actively involvedimmune tolerance and/or unresponsiveness, paradoxes
to this paradigm are often recognized. For example, in in suppressing inflammatory responses by inducing the
anti-inflammatory cytokines, IL-10 (Gao et al., 1998; Volltransplants, induction of apoptosis in the responding T
cells by costimulator block plus rapamycin promotes et al., 1997) and TGF- (Fadok et al., 1998). Previous
studies (Fadok et al., 1998) and our own data (W.C. ettolerance (Li et al., 1999; Wells et al., 1999), but it is
unclear why newly maturing T cells do not simply replace al., unpublished data) identified macrophages as one of
the cellular sources of TGF- triggered by ingestion ofthese deleted T cells and eliminate the graft after cessa-
tion of treatment (Ferguson and Green, 1999). Addition- dying cells. Whether apoptotic T cells produce or se-
crete TGF- to contribute to this suppressive milieu has,ally, the death of T cells specific for tumor or tumor-
associated antigen by Fas-dependent or -independent however, not yet been determined. In this study, we
present evidence that T cells express TGF-within theirpathways seemed a plausible explanation for immune
escape of neoplastic cells (Bodey et al., 1999; Gastman intracellular membrane-bound compartment that in-
cludes the mitochondria, release it during apoptosis,et al., 1999; Kiessling et al., 1999), yet proximal T cells
often appear incapable of promoting antitumor immu- and activate TGF- through a ROS-dependent mecha-
nism. TGF- released from apoptotic T cells likely con-nity. In another example, the immune deficiency associ-
ated with HIV-1 infection is mainly attributed to CD4 T tributes to resolution of inflammatory and immune re-
sponses and/or the generation of tolerance.cell death, but residual HIV-1 infected and/or uninfected
CD4 T cells may be unresponsive. Moreover, recent
studies indicate that the localized death of lymphoid Results
cells within the eye downregulates systemic immunity
Apoptotic T Cells Release TGF-
To study whether apoptotic T cells secrete TGF-, we1 Correspondence: wchen@dir.nidcr.nih.gov (W.C.), smwahl@dir.
nidcr.nih.gov (S.M.W.) first used a well-defined activation-induced cell death
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Figure 1. Apoptotic Peripheral T Cells Release TGF-
(A–C) Preactivated CD4 T cells (2  105 per well in 96-well plate) were exposed to immobilized anti-CD3 antibody (10 g/ml) in serum free
medium (X-Vivo-20) (solid bar) or medium only (hatched bar) for 24 and 48 hr. Cell death was determined by trypan blue exclusion assay (A).
Cell-free supernatants were collected for the determination of total TGF- (B) and active TGF- (C) by a TGF-1 Emax ELISA kit. Data represent
the mean  SD of duplicate wells of ELISA plates and are representative of at least three experiments. *, undetectable.
(D–F) Preactivated CD4 T cells were incubated with anti-Fas antibody (10 g/ml) for 30 min at 4C. Following extensive washes, cells (2 
105 per well) were added into culture plates with immobilized goat anti-hamster IgG antibody (10 g/ml) or restimulated with plate-coated
anti-CD3 mAb (10 g/ml) for 48 hr. Cell viability was determined by trypan blue exclusion and/or 7-AAD staining. (D) Specific cell death
induced by anti-Fas and anti-CD3 antibodies. The spontaneous apoptosis in medium only cultures was 25%–35%. Data are calculated as
100%  (1-(viable cells in antibody treated cultures/viable cells in medium control cultures)). Total TGF- (E) and active TGF- (F) in the
culture supernatants. The experiment was repeated twice with similar results.
(AICD) system in peripheral T cells (Van Parijs et al., Golstein, 1995; Van Parijs et al., 1996), CD4 T cells were
first stimulated with anti-CD3 mAb in the presence of1999). Murine spleen cells were stimulated with ConA
for 72 hr, and CD4 T cells were then isolated. After irradiated syngeneic spleen antigen- presenting cells
(APCs) for 3 days. After incubation with rIL-2 overnight,incubation with recombinant IL-2 overnight, the CD4
T cells were restimulated or not with plate-coated anti- CD4 T cells were induced to undergo apoptosis with
anti-Fas antibody crosslinked by plate-coated goat anti-CD3 mAb in serum-free medium (X-Vivo 20) for 24 and
48 hr. By 24 hr (Figure 1A), more than 90% of CD4 T hamster antibody (Van Parijs et al., 1998). By 48 hr,
20%–40% increase in apoptotic T cells was found incells were killed by anti-CD3 compared to 20%–30%
in untreated cultures. When supernatants from these anti-Fas treated compared to untreated (medium only)
cultures (Figure 1D). High levels of total TGF- werecultures were tested for TGF-, significantly increased
levels of total TGF- (acid treated) were detected in anti- observed in anti-Fas treated culture supernatants, which
exceeded the levels in parallel anti-CD3 treated cell cul-CD3 treated cultures, although the preactivated cells
without anti-CD3 restimulation also released detect- tures (Figure 1E), although the latter induced more than
90% of T cell death (Figure 1D). However, anti-Fas anti-able TGF- (Figure 1B). Unexpectedly, in the anti-CD3-
induced apoptotic cultures, biologically active TGF- body failed to cause a measurable increase in secreted
bio-active TGF- compared to T cells cultured in me-(without acid treatment) was also detected, although
the level was lower than total TGF- (Figure 1C). The dium only (Figure 1F), which was distinct from apoptosis
induced by anti-CD3 antibody in which both total andinduction of active TGF- appeared not due to the CD3/
TCR stimulation alone, since parallel treatment of freshly active TGF- were secreted (Figure 1).
isolated naive/resting CD4 T cells failed to lead to an
increase in active TGF- (Chen et al., 1998b) (data not Apoptotic Thymocytes Induced by -Irradiation
and Dexamethasone Release TGF-shown). These results demonstrated that AICD of T cells
initiated release of latent as well as active TGF-. In addition to peripheral T cells, apoptosis induced using
two well-defined thymocyte apoptosis induction regi-To extend these studies, we induced T cell apoptosis
by triggering death receptor Fas and evaluated TGF- mens,-irradiation (1200 rad), or dexamethasone (1M),
also augmented TGF- levels. Either -irradiation orsecretion. Since Fas-induced cell death does not occur
until late in the time course of intensive activation of dexamethasone resulted in the majority (80%–90% and
98%–99%, respectively) of thymocytes becoming apo-normal T cells (Boise and Thompson, 1997; Nagata and
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cell cultures (data not shown). Thus, it appears that as
apoptotic death progresses, T cells, in spite of different
induction pathways, release TGF-, although the quan-
tity and extent of TGF- activation may vary.
Release versus Synthesis of TGF-
We used two approaches to address whether TGF- in
apoptotic T cell cultures was released from intracellular
existing protein or programmed cell death promoted
new TGF- synthesis. First, freshly isolated thymocytes
were irradiated (1200 rad) and cultured for 2 hr, which
induced the majority of cells to initiate apoptosis path-
ways. By RT-PCR, no increase in TGF-1 mRNA was
observed in irradiated dying T cells compared to un-
treated thymocytes (Figure 3A). Secondly, TGF-1
mRNA of preactivated (ConAIL-2) peripheral CD4 T
cells programmed to die by anti-CD3 or anti-Fas anti-
body restimulation was examined by RNase protection
assay (RPA) (Chen et al., 1998a). No conclusive increase
in TGF- mRNA expression was found in the anti-CD3
treated T cells (2 hr) compared to the untreated control
cells (Figure 3B), despite the dramatic release of TGF-
protein in the treated cultures (Figure 1). These data
suggest that apoptotic T cells release intracellular exist-
ing TGF- rather than synthesize new protein.
Intracellular Source of TGF-
A previous report demonstrated TGF- within the mito-
chondria of rodent liver and heart cells (Heine et al.,
1991), prompting us to separate the membrane-bound
compartment including mitochondria from the cytosol
of T cells for assay of TGF-. Several-fold higher levels
of total TGF- were measured in the preparation con-
taining mitochondria and/or other vesicles than in the
cytosol of freshly isolated T cells by Western blot and
ELISA (Figure 3C, G Fresh). Moreover, by immunofluo-
rescence, TGF- staining could be colocalized with a
mitochondrial-specific dye (Figures 3D–3F). Following
treatment of thymocytes with -irradiation (1200 rad)
and culture at 37C to induce apoptosis, we measured
Figure 2. Thymocyte Apoptosis and Secretion of TGF- total TGF- in the mitochondria-enriched and cytosol
preparations (Figure 3G) by ELISA. Without culture afterThymocytes were isolated and pooled from B6/129 mice (4–6 weeks,
three to five mice per experiment) and resuspended in X-Vivo 20 irradiation (Figure 3G, 0 hr), most of the detectable
medium (1 106 per well) for culture as described in the Experimen- TGF- remained associated with the mitochondria or
tal Procedures. (A). Apoptosis of thymocytes was quantified by membrane-bound vesicles that copurify with mitochon-
staining with 7-AAD and FACScan analysis. Total (B) and active
dria. However, mitochondrial-associated TGF- of irra-(C) TGF- in the supernatants was determined by ELISA. Data are
diated cells significantly decreased within 4 hr and con-presented as mean  SD of duplicate cultures. Med, medium; Rad,
tinued to decrease for the 16 hr tested. By comparison,-irradiation; Dex, dexamethasone; and *, undetectable.
TGF- associated with cytosol showed a corresponding
increase (Figure 3G). Despite the continuing decrease
within the mitochondria-enriched preparation, TGF- inptotic by 16 hr in vitro (Figure 2A). Apoptosis was con-
cytosol remained relatively stable from 4–14 hr resultingfirmed by 7-AAD staining (Figure 2A) (Chen et al., 1998c)
in a reduction (400 pg/ml per 4  106 cells) of theas well as DNA fragmentation (data not shown) and was
amount of intracellular TGF-by the end of 16 hr, consis-associated with increases in total (Figure 2B) and active
tent with the levels of TGF- released into the superna-(Figure 2C) TGF- in culture supernatants. In parallel,
tants (100 pg/ml per 1  106 thymocytes) (Figure 2B).thymocytes treated with plate-coated anti-CD3 (10 g/
ml) also died (Figure 2A) and released enhanced total
(Figure 2B) and active (Figure 2C) TGF-. Since 7-AAD Association between Mitochondrial Membrane
Potential (m) and TGF-and trypan blue staining primarily detect late apoptotic
cells, thymocytes were next irradiated and cultured for Collapse of mitochondrial membrane potential (	m) is
a hallmark of cells committed to cell death (Kroemer, 1998).only 2–4 hr, when the majority of the cells were in the
early stage of apoptosis and were Annexin-V positive The loss of TGF- from the mitochondria-enriched com-
partment (Figure 3G) suggested an association with lossbut 7-AAD negative. Analysis of the supernatants re-
vealed no increase in TGF- in these early apoptotic of 	m. First, compared to controls (Figure 4A), thymo-
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Figure 3. TGF- mRNA and Protein Levels in
Apoptotic and Viable T Cells
(A and B) TGF- mRNA levels. Freshly iso-
lated thymocytes (pooled from three to five
mice) were treated with plate-coated anti-
CD3 mAb (10 g/ml), -irradiation (1200 rad),
or medium only at 37C, 5% CO2 for 2 hr. RNA
was isolated and assessed for TGF-1 by RT-
PCR (A). Thymocytes of TGF-1 null mice
(
/
) were included as a negative control for
RT-PCR. The experiment was repeated twice
with similar results. Rad, -irradiation. (B) As-
sessment of TGF- mRNA by RPA. Preacti-
vated peripheral CD4 T cells were restimu-
lated with anti-Fas (10 g/ml) cross-linked by
plate-coated goat anti-hamster IgG (10 g/
ml) or with plate-coated anti-CD3 antibodies
at 37C, 5% CO2 for 2 hr. RNA was isolated
and multiple template mCK3b set was used.
(C) Western blot analysis of TGF-1. The mi-
tochondria-enriched, membrane-bound com-
partment and cytosol were isolated from
pooled fresh thymocytes (five mice), and 20
g of each protein pool was loaded into each
lane. TGF-1 LAP was detected with anti-
LAP (TGF-1) antibody (R&D Systems). Mt,
mitochondrial preparation; and Cyto, cytosol.
(D–F) Immunofluorescence staining for TGF-1
and mitochondria. Spleen T cells were stained
with mitochondrial-specific dye MitoTracker
Red and chicken anti-TGF-1 antibody fol-
lowed by Cy2-conjugated F(ab)2 donkey anti-
chicken IgY as indicated. Cells were viewed
under the confocal fluorescence microscope
(100). (D) shows TGF- green immunostain-
ing. (E) shows mitochondrial red fluores-
cence. (F) represents an overlay of images
(D) and (E), in which yellow indicates the colo-
calization of TGF- with the mitochondrial
marker. The figure is a representative exper-
iment.
(G) Total TGF- levels within mitochondria-
enriched preparations and the kinetics of in-
tracellular redistribution of TGF- from the
vesicles/mitochondria to the cytosol in apo-
ptotic thymocytes. The thymocytes (4  106
cells) were irradiated (1200 rad) and cultured
for indicated lengths of time. The untreated
thymocytes are shown as Fresh.
cytes induced to die showed a corresponding loss of active TGF- (Khalil, 1999). To discern how TGF- was
activated during T cell apoptosis, we focused on reac-	m as determined by staining with DiOC6, a dye taken
up by mitochondria (Hildeman et al., 1999; Kroemer, tive oxygen species (ROS) that have been implicated
both in programmed cell death involving the loss of	m1998) (Figure 4A). Secondly, when thymocytes were irra-
diated, cultured, and the kinetics of their 	m measured (Hildeman et al., 1999) and in the activation of L-TGF-
(Barcellos-Hoff and Dix, 1996). Intracellular ROS can be(Figure 4B), a significant loss of 	m as determined by
the mean fluorescence intensity (MFI) of DiOC6 staining quantified by staining with dihydroethidium (Hildeman
et al., 1999). Whether induced by anti-CD3, -irradiation,was detected within 1 hr (Figure 4B), preceding the de-
crease in the mitochondria-associated TGF- (4–5 hr) or dexamethasone, apoptotic thymocytes showed in-
creased percent of ROS positive cells (Figure 5A), which(Figure 3G). Over 5 hr, the 	m of thymocytes continued
to decline (Figure 4B), consistent with the kinetics of corresponded to decreased 	m (Figure 4A) and in-
creased cell death (Figure 2A). Similar results were foundmitochondria-associated TGF- loss (Figure 3G) and im-
plicating an association of collapse of 	m with TGF- in apoptotic peripheral CD4 T cells induced by anti-CD3
mAb, but anti-Fas treatment failed to significantly increaserelease.
dihydroethidium positive cells (data not shown). To test
whether the ROS was involved in the loss of 	m andActivation of Apoptotic T Cell Latent TGF-
cell death and/or activation of latent TGF-, we includedIs Associated with Reactive Oxygen Species
a superoxide dismutase mimetic, Mn(III) tetrakis (5,10,15,TGF- is normally secreted in a latent form, L-TGF-,
and the latency associated peptide (LAP) in the N-termi- 20-benzoic acid) porphyrin (MnTBAP) (Hildeman et al.,
1999) that inhibits ROS, in the anti-CD3-induced CD4nal region must be cleaved or dissociated to produce
Apoptotic Cells Release TGF-
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Figure 4. Loss of 	m in Apoptotic Thymocytes
(A) Cells were treated (16 hr) as indicated. 	m was determined by intracellular staining with DiOC6 and FACScan analysis. The shown
percentages represent DiOC6low cells with reduced 	m.
(B) The kinetics of 	m loss during apoptosis. Thymocyte apoptosis was induced with -irradiation (1200 rad), and cells were cultured for 1–5
hr. The changes in mean fluorescence intensity (MFI) of DiOC6 cellular staining were measured by FACScan. The MFI of untreated thymocytes
without DiOC6 staining was 38, which was used as a negative control.
T cell apoptosis culture. MnTBAP failed to protect and/ TGF- antibody added to the cocultures restored TNF
production (data not shown), confirming a role for TGF-or rescue T cell apoptosis induced by anti-CD3 (Figure
in the suppression of LPS-induced macrophage TNF.5B), nor could it protect 	m in dying cells (data not
Since macrophages also produce and/or activateshown), implying that ROS may not be directly responsi-
TGF- upon phagocytosis of apoptotic cells (Fadok etble for T cell death mediated by CD3/TCR activation, but
al., 1998) (data not shown), it was necessary to deter-rather a consequence of the collapse of 	m (Kroemer,
mine which population, T cells or macrophages, contrib-1998). MnTBAP, however, almost completely abrogated
uted to the pool of active TGF- in cocultures. By com-the biologically active TGF- found in supernatants of
paring levels of active TGF- between TGF-1 nullapoptotic cells (Figure 5C). Thus, ROS from apoptotic
(Kulkarni et al., 1993; Shull et al., 1992) and wild-typeT cells appear responsible, at least in AICD, for activa-
macrophages exposed to TGF-1(/) apoptotic thy-tion of latent TGF-.
mocytes, we confirmed that apoptotic T cells in fact
released active TGF- (Figure 6C), since the superna-
Apoptotic T Cell TGF- Suppresses Macrophage tants of TGF- null macrophages plus wild-type apoptotic
Inflammatory Cytokines T cells contained detectable levels of active TGF-. Thus,
Murine macrophages were stimulated with bacterial li- apoptotic T cells, in addition to the macrophages clear-
popolysaccharide (LPS) in the presence or absence of ing these cells, release TGF-, which contributes to the
apoptotic thymocytes. LPS induced high levels of TNF downregulation of macrophage inflammatory functions
in macrophages (Figures 6A and 6B). In the presence of and likely also impairs viable T cell activation.
apoptotic cells, the TNF production was reduced when
determined either by intracellular cytokine staining (Fig- Apoptotic Liver Cells Release Active TGF- In Vivo
ure 6A) or, more dramatically, by measurement of the To establish whether the release of active TGF- was
unique to suicidal T cells, we assayed apoptosis of livercytokine in the culture supernatants (Figure 6B). Anti-
Immunity
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Figure 5. ROS Is Associated with the Activation of Latent TGF-
(A) Measurement of intracellular ROS by staining with dihydroethidium. Thymocytes were treated as indicated for 16 hr, stained with dihydro-
ethidium, and analyzed by FACScan. The percentages represent dihydroethidiumhi (ROShi) cells.
(B and C) MnTABP failed to prevent TCR-mediated T cell death but abrogated active TGF- in culture supernatants. Spleen cells were
preactivated with ConA for 3 days, followed by IL-2 incubation overnight. Purified CD4 T cells (2  105 per well) were restimulated with or
without plate-coated anti-CD3 mAb (10 g/ml) in the presence or absence of MnTABP (100 M) for 48 hr. The viable cells were counted by
trypan blue exclusion (B), and active TGF- in the supernatants was determined by ELISA (C). Med, medium, CD3, anti-CD3 antibody; and
*, undetectable.
cells and circulating levels of active TGF- in a well- volved during programmed cell death and the processes
of apoptotic cell clearance (Fadok et al., 1998; Gao etdefined mouse model (Ogasawara et al., 1993). In this
model, massive apoptosis of liver cells is induced by al., 1998; Voll et al., 1997). We provide here direct evi-
dence that apoptotic T cells release latent as well asinjection of anti-Fas antibody (Jo2, 10 g per mouse)
(Figures 7A and 7B) without dramatically affecting other active TGF-, which contributes to this anti-inflamma-
tory milieu. Several unprecedented conclusions can beorgans in normal mice (Ogasawara et al., 1993). Signifi-
cantly, sera of anti-Fas antibody injected mice showed drawn from the current study. First, once programmed
to become apoptotic, whether induced by TCR restimu-much higher levels of active TGF- than that in untreated
controls (Figure 7E, wild-type). This was further verified lation, death receptor signaling, or nonspecific -irradia-
tion, T cells intend to release TGF-. Variations in TGF-by the fact that injection of the same anti-Fas antibody
into Fas null mice (B6.MRL-Faslpr) failed to increase ac- levels from apoptotic T cells may reflect not only subtypes
and numbers of apoptotic cells but also the strengthtive TGF- in sera (Figure 7E, Fas
/
), since no apoptosis
of hepatocytes was induced (Figures 7C and 7D). Thus, and features of specific death signals. One of the noted
findings is that anti-Fas antibody (Jo2) triggers releaseapoptotic hepatocytes also release TGF- in vivo indi-
cating that apoptotic cell release of TGF- is not a T cell of higher amounts of total TGF- than anti-CD3, al-
though the former induces less T cell death than therestricted event, but rather a more general phenomenon.
latter. These data indicate that Fas-mediated signaling
may have an alternative/additional pathway to engageDiscussion
TGF- secretion. Second, release rather than synthesis
of TGF- during the apoptotic process is the most plau-Evidence is emerging that complex active suppression,
rather than simple passive lack of inflammation, is in- sible explanation for the appearance of TGF- in the
Apoptotic Cells Release TGF-
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Figure 6. TGF- Derived from Apoptotic T Cells Contributes to the Deactivation of Inflammatory Response
(A) Intracellular staining of TNF in LPS (10 ng/ml) activated macrophages. Macrophages were dual-stained with PE-conjugated anti-CD14
for surface marker and FITC-conjugated anti-TNF for intracellular cytokine. Cells were analyzed by FACScan. (a) Negative control with the
isotypic antibodies; (b) macrophages were treated with medium only (X-Vivo-20); (c) macrophages were treated with LPS; (d) macrophages
preincubated with apoptotic thymocytes (1  106 per 2  105 macrophages) were stimulated with LPS. MFI, mean fluorescence intensity.
(B) TNF levels in the supernatants were determined by ELISA. Med, medium; and Apo: apoptotic thymocytes (1  106 per well). Data are
presented as mean  SD of duplicate cultures.
(C) Active TGF- in the supernatants of macrophage and apoptotic thymocyte cocultures. Macrophages (2  105 per well); Med, medium;
and Apo, apoptotic thymocytes (1  106 per well). Data are presented as mean  SD of duplicate cultures.
supernatants, since there is no compelling evidence for membrane permeability may influence this redistribu-
tion. Fourth, that apoptotic T cells release not only latentincreased transcription of TGF- in the apoptotic T cells.
Third, TGF- was associated with a membrane-bound but also active TGF- emphasizes the contribution of
apoptotic cells themselves in preventing and/or sup-intracellular compartment and redistributed into the cy-
tosol and medium following the collapse of 	m during pressing the potential inflammatory response, since only
bio-active TGF- can function through the TGF- recep-apoptosis. Our data show that higher TGF- is found in
mitochondria and/or in vesicles that copurify with mito- tor signaling pathway (Derynck et al., 1998; Gorelik and
Flavell, 2000; Letterio and Roberts, 1998; Massague,chondria than in the cytosol of T cells, and is consistent
with the previous finding that TGF- is localized within 1998; Yang et al., 1999). The fact that MnTBAP, an antag-
onist of ROS, abrogates nearly all active TGF- but failsliver and heart cell mitochondria (Heine et al., 1991;
Sporn, 1999). The mitochondrion has been referred to to prevent the reduction of 	m and rescue T cells from
death has important implications: ROS is involved inas the common effector of cell death (Kroemer, 1998;
Kroemer et al., 1997) even though the “private” or selec- activating latent TGF- during T cell apoptosis; and ac-
cumulated ROS, at least in anti-CD3-induced cell death,tive death signaling may vary, and the collapse of 	m
represents the no-return point in cell death. The kinetics is a consequence rather than a cause of the collapse
of 	m. Finally, active TGF- released from apoptoticof redistribution of intracellular TGF- and its close as-
sociation with the reduction of	m during T cell apopto- T cells clearly contributes to suppressed production of
proinflammatory cytokines by macrophages and/or by-sis favor TGF- release as a consequence of the col-
lapse of 	m. It has been noted, at least in apoptotic stander immune reactive T cells, although the “no in-
flammation” state during apoptosis and clearance ofthymocytes induced by irradiation, that only a portion
of intracellular TGF- is released into the supernatants. dead cells may involve complex processes and multiple
cell participation (Fadok et al., 1998; Gao et al., 1998;How intracellular TGF- is released into the external
milieu of apoptotic cells is unknown, albeit changes of Griffith et al., 1996; Voll et al., 1997). In short, the data
Immunity
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Figure 7. Apoptotic Liver Cells Release Active TGF- In Vivo
(A–D) Massive apoptosis of liver cells in B6 wild-type (B) but not Fas null (D) mice injected with anti-Fas antibody (10 g per mouse). Livers
were harvested 2–6 hr after antibody injection and fixed with 10% neutral buffered formalin. Tissues from mice injected with PBS (A and C)
or anti-Fas (B and D) were stained with H&E and examined under light microscope (original magnification, 63). Arrows in (A), (C), and (D)
indicate typical hepatocyte nuclei. Following anti-Fas mAb there is massive death of hepatocytes in wild-type livers with dense pyknotic or
broken nuclei (arrows in [B]) but not in Fas null livers (D). R, red blood cells. (E) Active TGF- in sera. Sera were collected from the mice 2–6
hr after anti-Fas and pooled from each group (three to five mice). Sera were diluted (1:20) with the sample buffer before assay (without acid
activation) for TGF-1 by ELISA.
shown in this study have clearly broadened the potential function of the immune system. On the one hand, as in
Fas or FasL (Nagata, 1997; Nagata and Golstein, 1995),mechanisms underlying immune tolerance and/or im-
mune deficiency associated with T cell apoptosis. or IL-2 (Klebb et al., 1996; Sadlack et al., 1993, 1995)
deleted mice, the most important pathway to induceThe balance between sufficient apoptosis of “danger-
ous” and/or damaged lymphocytes and adequate levels apoptosis of T cells is abrogated. Subsequently, T cell
activation and proliferation go unchecked and neitherof anti-inflammatory cytokines during their clearance
is a prerequisite to maintain normal homeostasis and T cells, unable to commit to suicide, nor macrophages,
Apoptotic Cells Release TGF-
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CA). Dye 3,3-dihexyloxacarbocyanine iodide (DiOC6) and dihydroe-without apoptotic T cells to digest, can control the re-
thidium were from Molecular Probes (Eugene, OR).sponse through releasing anti-inflammatory cytokines
such as TGF- and/or IL-10. On the other hand, as in
Preparation of CD4 T Cells
TGF-1 null (Kulkarni et al., 1993; Shull et al., 1992) and/ Spleens and lymph nodes were harvested and the tissues were
or perhaps in IL-10 mutated mice (Kuhn et al., 1993), gently minced in complete DMEM containing 10% FBS (BioWhit-
the ability to produce these crucial anti-inflammatory taker, Walkersville, MD) as described (Chen et al., 1998b). Cells
were then passed through a cell strainer (Becton Dickinson, Franklincytokines by T cells and macrophages is lacking, al-
Lakes, NJ) and red blood cells lysed with ACK lysing buffer (BioWhit-though these mice have normal (Kuhn et al., 1993) or
taker). For CD4 T cell isolation, cells were purified by using a mouseeven increased T cell apoptosis (W.C. et al., unpublished
CD4 T Cell Column System (R&D Systems). By FACS analysis, the
data). The net effect in each of these null mice may be purity of CD4 T cells was usually 95% with no detectable B cells
a deficiency in negative regulatory molecules, and the or monocytes. In some experiments, -irradiated T cell depleted-
mice unavoidably develop uncontrolled inflammation spleen cells (3000 rad) were used as antigen-presenting cells (APCs).
and “autoimmune”-like diseases.
Induction of Peripheral T Cell Apoptosis In VitroThe present study may provide insight for exploring
For AICD through the CD3/TCR complex, spleen cells (1  106/ml)the mechanisms of immune tolerance, immune escape,
were cultured in complete DMEM with ConA (2 g/ml) (Sigma) forand/or deficiency in clinical situations. Both apoptotic
3 days. CD4 T cells were then column purified (R&D Systems) and
T cells and phagocytic macrophages may contribute to re-incubated with recombinant rIL-2 (50 u/ml) overnight. T cells (2 
a state of immune unresponsiveness via secretion of 105/well) were then restimulated with anti-CD3 mAb (10 g/ml) pre-
TGF- and/or IL-10. This complex immunoregulatory pro- coated onto 96-well plates (Costar, Cambridge, MA) in serum free
X-Vivo 20 culture medium (BioWhittaker) for 24 and 48 hr. For cellcess may favor acceptance of transplanted organs (Li
death induced by Fas cross-linking, purified CD4 T cells wereet al., 1999; Wells et al., 1999) or tolerance induction in
stimulated with anti-CD3 mAb (0.5 g/ml) in the presence of synge-response to high-dose antigen administration in experi-
neic APCs for 3 days. Viable cells were incubated with hamster anti-
mental autoimmune disease models (Chen and Wahl, Fas mAb (Jo2) at 4C for 30 min. After being washed, cells (2  105/
1999; Chen et al., 1995, 1998a; Strober et al., 1997), well) were then added into the plates precoated with goat anti-
together with the induction of Th3-like cells (Chen et al., hamster antibody (10 g/ml). Cell-free supernatants were collected
at 48 hr for detection of cytokines. Cell viability was assayed with1995). The escape of tumor cells from immune surveil-
trypan blue exclusion and/or 7-AAD staining (Chen et al., 1998b).lance may involve not only Fas-mediated and/or other
death pathways for killing tumor-specific T cells (Bodey
Induction of Thymocyte Apoptosis In Vitroet al., 1999; Gastman et al., 1999; Kiessling et al., 1999),
Thymocytes were cultured with plate-coated anti-CD3 mAb (10 g/
but also the concomitant release of immunosuppressive ml) or with dexamethasone (1 M). For apoptosis induced by
cytokines. In HIV-1 infection, particularly in the later -irradiation, thymocytes were irradiated (1200 rad) before being
added into the plates. Cells were then cultured in serum-free X-Vivostage of AIDS, death of CD4 T cells as well as the con-
20 medium for 16 hr. As parallel controls, thymocytes were eithersequent release of immunosuppressive cytokines such
cultured with medium at 37C or at 4C. Cell viability was determinedas TGF- (Hu et al., 1996; Kekow et al., 1990; Sher et
with 7-AAD staining or trypan blue exclusion. In some experiments,al., 1992; Wahl et al., 1991; Zauli et al., 1996) may underly
early apoptotic cells were detected by Annexin-V-PE, together with
the exhaustive immune deficiency that occurs even 7-AAD (Annexin-V 7-AAD
). Culture supernatants were collected
when some uninfected CD4 T cells still remain. By refo- at 16–24 hr for cytokine measurement.
cusing our investigation on the apoptotic cell in addition
Cytokine ELISAsto the previously determined phagocytic cell as the
Active TGF-1 in the culture supernatants was determined directlysource of the immunosuppressive activity, it may be-
by the TGF-1 Emax ImmunoAssay System (Promega Corp., Madi-come possible to manipulate host offense and defense.
son, WI). For total TGF-1 measurement, samples were first treated
with 1N HCl (1 l per 50 l supernatant) for 15 min at room tempera-
Experimental Procedures ture and neutralized with an equal amount of 1N NaOH before analy-
sis in the ELISA. Serum was usually diluted 1:20 with the kit sample
Mice buffer before TGF-1 assay. Quantitative analysis for TNF was
TGF-1(
/
) (C57BL/6xSv129) mice were generated by disruption performed using the ELISA kit purchased from Biosource Interna-
of the TGF-1 gene in murine embryonic stem cells by homologous tional (Gaithersburg, MD).
recombination (Kulkarni et al., 1993), and their wild-type littermates
were bred and maintained in a specific pathogen-free rodent facility Assessment of TGF- mRNA
at the National Institute of Dental and Craniofacial Research, NIH. Total RNA was isolated from cells using a modified guanidinium
Mice homozygous for Fas mutation (B6.MRL-Faslpr) and their wild- isothiocyanate method (RNeasy Kit, Qiagen, Chatsworth, CA). Semi-
type controls were purchased from The Jackson Laboratory (Bar quantitative reverse transcriptase-PCR (RT-PCR) for TGF-1 mRNA
Harbor, ME). was performed as described (McCartney-Francis et al., 1997). HPRT,
a housekeeping gene, was used to verify cDNA synthesis from each
RNA sample and to enable comparison of RNA levels between differ-Antibodies and Reagents
ent samples. For RNase protection assays (RPA) (Chen et al., 1998a),Hamster anti-murine CD3 (Clone 145-2C11, NA/LE), Fas (Clone Jo2,
multiple template mCK3b set (PharMingen) was used, and radiola-NA/LE), purified IgG isotypic control antibody (Clone G235-2356,
beled probes were generated using (33P)dUTP (New England Nu-NA/LE), and Annexin V-PE Apoptosis Kit were purchased from Phar-
clear, Boston, MA).Mingen (San Diego, CA). Rat anti-murine FITC-CD4 (clone CT-CD4)
and the respective isotypic control mAbs were purchased from Cal-
Tag Laboratory (San Francisco, CA). Mouse anti-TGF-1, 2, 3 mAb Mitochondria and Cytosol Preparations
Mitochondria were isolated according to the published protocolwas from R&D Systems (Minneapolis, MN). Goat anti-hamster IgG
(HL) antibody was from Pierce (Rockford, IL). Recombinant IL-2 (Yang et al., 1997). In brief, the T cell pellets were washed with ice-
cold PBS and resuspended with five volumes of buffer A (20 mMwas purchased from Boehringer Mannheim (Indianapolis, IN). 7-amino-
actinomycin D(7-AAD) and Mn(III) tetrakis (5,10,15,20-benzoic acid) Hepes-KOH [pH 7.5], 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium
EDTA, 1 mM sodium EGTA, 1 mM dithiothreitol, and 0.1 mM phenyl-porphyrin (MnTBAP) were purchased from Calbiochem (La Jolla,
Immunity
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methylsulfonyl fluoride) containing 250 mM sucrose (thymocytes: Assessment of Effects of Apoptotic T Cells on Macrophage
TNF Production100  106 cells in 500 l; peripheral T cells: 15–20  106 cells in
200–250 l). The cells were homogenized with 10 stroke of a Teflon Peritoneal macrophages were collected by lavage with ice-cold PBS
without Ca2 and Mg2 and washed twice with PBS before resuspen-homogenizer, and the homogenates were centrifuged twice at 750g
for 10 min at 4C. The pellets were discarded and the supernatants sion in complete DMEM. Macrophages were adhered (2  105 per
well) in a 96-well flat-bottom plate in prewarmed DMEM for 2 hr atwere centrifuged at 10,000g for 15 min at 4C. The resulting mito-
chondrial-enriched pellets were washed and resuspended in the 37C, 5% CO2, and nonadherent cells washed off with X-Vivo-20.
To some cultures, apoptotic thymocytes (1  106) that had beenoriginal volumes of buffer A and frozen at -80C. The supernatants
of the 10,000g spin were further centrifuged at 100,000g for 1 hr at irradiated and cultured for 3 hr at 37C were added overnight. LPS
(10 ng/ml) was added as indicated. Supernatants were collected at4C, and the resulting supernatants (cytosol) were frozen at 
80C
for further experiments. The samples (20 l) were diluted (1:5) with 24 hr for cytokine ELISAs.
For detection of intracellular TNF, macrophages preincubatedthe sample dilution buffer included in the TGF-1 ELISA kit before
analysis for TGF-1. overnight with or without apoptotic thymocytes were stimulated
with LPS (10 ng/ml) for 4–6 hr at 37C, 5% CO2 in the presence of
GolgiPlug (1 l/ml, PharMingen) to block secretion. The macro-
Western Blot phages were first stained with PE-anti-murine CD14 mAb (Phar-
Aliquots of mitochondrial preparation and cytosol (20 g protein) Mingen) on ice for 30 min. After washing, the cells were stained
were subjected to 12.5% SDS-polyacrylamide gel electrophoresis for intracellular TNF with FITC-anti-murine TNF mAb using the
(SDS-PAGE) and transferred to a nitrocellulose filter (Schleicher & Cytofix/Cytoperm Plus kit (PharMingen) following the manufactur-
Schull, Keene, NH). The nitrocellulose membrane was blocked for er’s protocol. PE-or FITC- labeled isotypic antibody controls for
1 hr by using 5% instant skim milk powder in TBS (20 mM Tris-HCl surface and intracellular staining were also used before analysis by
[pH 7.6], 137 mM NaCl, and 0.1% Trition X-100). The filter was probed FACScan with the software Lysis II.
by an antibody to LAP-TGF-1 (anti-rhLAP, 0.2 g/ml, R&D Sys-
tems). After washing, the nitrocellulose membrane was incubated
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Freshly isolated spleen T cells were incubated with mitochondrion-
selective dye MitoTracker Red CMXRos (50 nM) (Molecular Probes, References
Eugene, OR) in complete DMEM at 37C for 40 min. After washing
with warm phosphate-buffered saline (PBS), cells were fixed with Barcellos-Hoff, M.H., and Dix, T.A. (1996). Redox-mediated activa-
Cytofix/Cytoperm (Cytofix/Cytoperm Plus Kit, PharMingen) at 4C tion of latent transforming growth factor-beta 1. Mol. Endocrinol.
for 20 min. Cells (1  106) were washed with Perm/Wash Buffer 10, 1077–1083.
(PharMingen) and incubated with chicken anti-human TGF-1 (10
Bodey, B., Bodey, B., Jr., Siegel, S.E., and Kaiser, H.E. (1999). Fas
g, R&D Systems) at 4C for 30 min. Cells were washed twice with
(Apo-1, CD95) receptor expression in childhood astrocytomas. Is it
Perm/Wash Buffer and stained with Cy2-conjugated F(ab)2 donkey a marker of the major apoptotic pathway or a signaling receptor for
anti-chicken IgY antibody (Jackson ImmunoResearch Laboratories,
immune escape of neoplastic cells? In Vivo 13, 357–373.
West Grove, PA) at 4C for 30 min. For negative staining controls,
Boise, L.H., and Thompson, C.B. (1997). Bcl-x(L) can inhibit apopto-MitoTracker Red stained cells were incubated with secondary Cy2-
sis in cells that have undergone Fas-induced protease activation.conjugated antibody only without adding anti-TGF-1 antibody.
Proc. Natl. Acad. Sci. USA 94, 3759–3764.After two washes, cells were resuspended in staining buffer (PBS-
BSA[0.5%]-Az[0.1%]) and subjected to confocal fluorescence Chen, W.J., and Wahl, S.M. (1999). Manipulation of TGF-beta to
microscopy. control autoimmune and chronic inflammatory diseases. Microbes
Infect. 1, 1367–1380.
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